You are here: Fairness.com > Resources > Where Cancer Progress Is Rare, One ...

Where Cancer Progress Is Rare, One Man Says No (Forty Years' War)

Date: September 15, 2009

Author: Gardiner Harris

QUOTE: cancer has proven difficult to crack, leading to frustration among executives and advocates who wonder why the Food and Drug Administration is not approving more drugs.

• Read it: New York Times
• Tell a friend
• Add a Comment*

Article MetaInformation:

Key People:

• Tony Fiorino
• Fran Visco
• Dr. Richard Pazdur M.D.
• Steve Walker

Key Organizations:

• Abigail Alliance for Better Access to Developmental Drugs
• American Cancer Society, Inc. (ACS)
• American Society of Clinical Oncology (ASCO)
• EnzymeRx
• Food and Drug Administration (FDA)
• National Breast Cancer Coalition
• New York Times Company
• Pharmacyclics
• Vion Pharmaceuticals

Subject & Geographic Categories:

• Abstract Principles
  • Control / Access / Permission
    • Choices/Tolerance/Flexibility
  • Information
    • Measurement
  • Responsibility
    • Credentials / Experts / Background
  • Risk Taking

• Government & Politics / History
  • Government (General)
    • Government Regulation
      • Business Regulation

• Health & Medicine
  • Drugs: Prescription/Non-Prescription
  • Health Care Business
    • Pharmaceutical / Drug / Biotech
  • Medical Ethics
  • Patient Rights
  • Public Safety/Health

• Science & Technology
  • Research Ethics
  • Technological Risk/Innovation/Utilization

• North America
  • United States of America/USA

Comments:

none

• Add a Comment*

*User comments are posted without Fairness.com LLC's prior review or approval, and Fairness.com LLC takes no responsibility for them; please see our Conditions of Service Agreement.

Please send your comments and suggestions to the Webmaster. © copyright 1999-2009, Fairness.com LLC.
"Fairness.com" and "Life isn't fair... but we're working on it" are service marks of Fairness.com LLC. All rights reserved.